It is a pharma private limited company based in Thane, Maharashtra, India, established in 2016.
2016 | Thane, Maharashtra, India | ActiveUnifab Pharmaceuticals Private Limited, a active private limited company, was established on 29 August 2016 in Thane, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2016PTC285270. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Mohammad Gulam (Whole-Time Director), Mohammed Asif Shaikh (Whole-Time Director), Majid Assim Shaikh (Director). Past directors included Smita Pillai, Mohemmed Saleem, Azhar Assim Shaikh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 9, Jay Residency Near Ram Rahim Nagar Gokhiware, Thane 401202, Thane, Maharashtra, 401202.
U74999MH2016PTC285270
285270
29 August 2016
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Unifab Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohammad Gulam | Whole-Time Director | 01 Mar 2022 | Current |
| Mohammed Asif Shaikh | Whole-Time Director | 01 Mar 2022 | Current |
| Majid Assim Shaikh | Director | 23 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Mar 2022 | Past |
| Pramod Abcsdd | Director | 23 Jan 2021 | Past |
| Pramod Abcsdd | Director | 09 Sep 2017 | Past |
| Pramod Abcsdd | Director | 12 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unifab Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 523.78% increase. The company also saw a substantial improvement in profitability, with a 858.83% increase in profit. The company's net worth Soared by an impressive increase of 848.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Unifab Pharmaceuticals had a promoter holding of 86.00% and a public holding of 14.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unifab Pharmaceuticals has a workforce of 2 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Unifab Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unifab Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Unifab Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Unifab Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Mohammad Gulam was appointed as a Whole-time director was appointed as a Whole-time director on 01 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
The activity Mohammed Asif Shaikh was appointed as a Whole-time director was appointed as a Whole-time director on 01 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
The activity Majid Assim Shaikh was appointed as a Director was appointed as a Director on 23 Jan 2021 & has been associated with this company since 4 years 10 months . was completed.
Unifab Pharmaceuticals Private Limited was registered on 29 Aug 2016 with Roc Mumbai & aged 9 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Unifab Pharmaceuticals Private Limited is U74999MH2016PTC285270.
Unifab Pharmaceuticals Private Limited is headquartered at Shop No. 9, Jay Residency Near Ram Rahim Nagar Gokhiware, Thane 401202, Thane, Maharashtra, 401202.
Unifab Pharmaceuticals Private Limited was incorporated on 29 August 2016.
The current directors of Unifab Pharmaceuticals Private Limited are
The primary industry of Unifab Pharmaceuticals Private Limited is Pharma.
Unifab Pharmaceuticals Private Limited is unlisted.
The authorized capital of Unifab Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Unifab Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX